Abstract
The aim of this study was to ascertain whether assessing the growth fraction of cervical carcinoma of 28 patients, using antibody Ki-67, would be of value in clinical practice. The results showed no relationship between growth fraction and age, clinical stage, lymph node involvement or short term (3-5 years) survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cole, D., Brown, D., Crossley, E. et al. Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis. Br J Cancer 65, 783–785 (1992). https://doi.org/10.1038/bjc.1992.167
Issue Date:
DOI: https://doi.org/10.1038/bjc.1992.167
This article is cited by
-
Hypoxia Markers in Human Osteosarcoma: An Exploratory Study
Clinical Orthopaedics and Related Research (2008)